ESR1 and breast carcinoma: Specifically, resveratrol of low dosage could stimulate the growth of ERα+ (estrogen receptor α positive) breast cancer cells, while it always acts as an inhibitor in ERα- (estrogen receptor α negative) breast cancer cells by acting as an estrogen-metabolizing inhibitor to affect the proliferation of different types of breast cancer cells [26].